Effect of GLANATEC ophthalmic solution 0.4% on corneal endothelium

Effect of GLANATEC ophthalmic solution 0.4% on corneal endothelium - Effect of GLANATEC ophthalmic solution 0.4% on corneal endothelium

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018340

Enrollment

Registered

2015-08-01

Start date

2015-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Normal subject

Interventions

Administration of GLANATEC ophthalmic solution 0.4% (single dose administration)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Normal subject

Exclusion criteria

Exclusion criteria: Corneal disease

Design outcomes

Primary

Measure	Time frame
Morphological change	—

Countries

Japan

Contacts

Public ContactNaoki Okumura

Doshisha university Department of Biomedical Engineering

nokumura@koto.kpu-m.ac.jp0774-65-6508

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026